Evidence map›Paper›PMID 26805882›Full record

ReviewToxins2016

The Biochemical Toxin Arsenal from Ant Venoms.

Axel Touchard, Samira R Aili, Eduardo Gonçalves Paterson Fox, Pierre Escoubas, Jérôme Orivel, Graham M Nicholson, Alain Dejean

Abstract readReview
In one paragraph

Review in Toxins, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 75 papers.

0numbers the graph read from it
0cells of the map it votes in
75citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

75 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. The Helix Ring Peptide UMembranes · 2024
    Article
  20. Article

15 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Axel TouchardCNRS, UMR Écologie des Forêts de Guyane (AgroParisTech, CIRAD, CNRS, INRA, Université de Guyane, Université des Antilles), Campus Agronomique, BP 316, Kourou Cedex 97379, France. t.axel@hotmail.fr.
Samira R AiliNeurotoxin Research Group, School of Medical & Molecular Biosciences, University of Technology Sydney, Broadway, Sydney, NSW 2007, Australia. samira.aili@uts.edu.au.
Eduardo Gonçalves Paterson FoxRed Imported Fire Ant Research Center, South China Agricultural University, Guangzhou 510642, China. ofoxofox@gmail.com.
Pierre EscoubasVenomeTech, 473 Route des Dolines-Villa 3, Valbonne 06560, France. escoubas@venometech.com.
Jérôme OrivelCNRS, UMR Écologie des Forêts de Guyane (AgroParisTech, CIRAD, CNRS, INRA, Université de Guyane, Université des Antilles), Campus Agronomique, BP 316, Kourou Cedex 97379, France. Jerome.Orivel@ecofog.gf.
Graham M NicholsonNeurotoxin Research Group, School of Medical & Molecular Biosciences, University of Technology Sydney, Broadway, Sydney, NSW 2007, Australia. graham.nicholson@uts.edu.au.
Alain DejeanCNRS, UMR Écologie des Forêts de Guyane (AgroParisTech, CIRAD, CNRS, INRA, Université de Guyane, Université des Antilles), Campus Agronomique, BP 316, Kourou Cedex 97379, France. alain.dejean@wanadoo.fr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ants (Formicidae) represent a taxonomically diverse group of hymenopterans with over 13,000 extant species, the majority of which inject or spray secretions from a venom gland. The evolutionary success of ants is mostly due to their unique eusociality that has permitted them to develop complex collaborative strategies, partly involving their venom secretions, to defend their nest against predators, microbial pathogens, ant competitors, and to hunt prey. Activities of ant venom include paralytic, cytolytic, haemolytic, allergenic, pro-inflammatory, insecticidal, antimicrobial, and pain-producing pharmacologic activities, while non-toxic functions include roles in chemical communication involving trail and sex pheromones, deterrents, and aggregators. While these diverse activities in ant venoms have until now been largely understudied due to the small venom yield from ants, modern analytical and venomic techniques are beginning to reveal the diversity of toxin structure and function. As such, ant venoms are distinct from other venomous animals, not only rich in linear, dimeric and disulfide-bonded peptides and bioactive proteins, but also other volatile and non-volatile compounds such as alkaloids and hydrocarbons. The present review details the unique structures and pharmacologies of known ant venom proteinaceous and alkaloidal toxins and their potential as a source of novel bioinsecticides and therapeutic agents.

Indexed as

AlkaloidsAnimalsAntsAnt VenomsHumansInsect ProteinsPeptidesAlkaloidsAnt VenomsInsect ProteinsPeptidesalkaloidsant venomenzymesformic acidpeptidestoxinsvenom biochemistry

Identifiers

PMID26805882
PMCPMC4728552

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.